Cardiac AI: Unlocking Enterprise Value in Chronic Heart Care

Everyone talks about virtual care saving money and making chronic heart health easier to manage. But for investors looking at the digital health market, the marketing slides are useless. The real story is in the messy, difficult operational work of scaling these platforms inside enterprise benefits packages. That “digital front door” to heart care? It’s not a smooth portal. It’s a gauntlet of friction points, especially when you’re trying to work with the spaghetti of health plan and employer benefits systems.

The Hidden Friction Points in Scaling Chronic Heart Health Platforms

Of course there’s excitement about AI in healthcare, especially with cardiac AI’s total addressable market (TAM) projected to jump from $1.7 billion to $14.8 billion by 2033. But behind the impressive clinical outcomes and slick pitches, these virtual heart health platforms are hitting a wall with enterprise adoption. Our own interviews with benefits managers and a close look at health plan formulary listings tell a different story. The “inside story” is all about nightmarish integration projects, wildly inconsistent payer coverage for virtual cardiology, and a relentless focus on 6- and 12-month patient retention metrics. The fact that average implementation timelines keep ballooning past what was promised just proves how tough the operations really are.

“Many virtual care platforms present compelling clinical data, but the rubber meets the road when they try to integrate with our existing IT infrastructure and demonstrate tangible ROI that goes beyond just engagement scores,” commented a benefits manager from a large national payer. “The ‘digital front door’ needs to open smoothly into our existing systems, not require us to rebuild the house.”

Lark Health, Vida Health, and Onduo: Working through the Payer Labyrinth

Let’s look at how a few of the big names in chronic care, particularly those with serious cardiometabolic programs, are dealing with this reality.

Lark Health: AI Chronic Care Coaching and the Integration Challenge

Take Lark Health. Their AI chronic care coaching seems like a perfect fit for managing hypertension and diabetes, which are tied to so many cardiac cases. And because their whole platform is AI-native, you’d think they’d have a lean operational model. The problem is, how do you get those AI insights to actually flow into a hospital’s existing electronic health records (EHRs) or a health plan’s care coordination workflow? Our interviews show that while their patient engagement AI is good, the bidirectional data exchange is a constant headache. Payer coverage for these services isn’t a given, either. Health plans are getting much tougher, demanding real-world evidence (RWE) of better outcomes and real cost savings, not just pilot data, before they’ll pay. Payer coverage criteria for virtual care platforms are getting stricter, and this applies directly to patient retention, where you have to prove people are still using the platform to get your per-member-per-month (PMPM) fees.

Vida Health: Cardiometabolic Management and Retention Metrics

Vida Health comes at it with a wider net, using a hybrid of human coaches and digital tools for cardiometabolic management. This approach appeals to investors because it means they can go after multiple chronic conditions in one enterprise client, expanding their addressable market. But here’s the rub: Vida and platforms like it have to prove their 6- and 12-month patient retention is better than what you get from a pure-digital app or just traditional care. Looking at health plan formularies, it’s clear payers now favor platforms that can show hard numbers on improved clinical markers and lower downstream healthcare costs. So, while the all-in-one offering looks good, the “inside story” is that the operational lift for a health plan to get a platform that broad onboarded and integrated is huge, which kills their average implementation timelines.

Onduo: Chronic Care Platform and the Enterprise Adoption Journey

Onduo’s story is a perfect example of the market’s brutality. It started as a virtual chronic care platform for diabetes, but as of January 2026, it’s being shut down and its programs are getting absorbed into Verily Me, a new care management solution. It shows how fast things change and that even platforms with serious backing aren’t safe. The whole “digital front door” concept papers over the fact that health plans and big employers are deeply risk-averse. They don’t just sign up. They demand ironclad security protocols (HIPAA, HITRUST, SOC 2 Type II are just table stakes) and a clear plan for regulatory de-risking, especially adherence to GMLP (Good Machine Learning Practice) if AI is doing any of the heavy lifting. HITRUST certification requirements for digital health are no joke. Often, the thing that drags out implementation timelines for enterprise clients isn’t the vendor’s tech, it’s the buyer’s own internal change management capabilities.

The Investor’s Lens: Critical Operational Questions for Due Diligence

If you’re an investor, you have to see past the marketing fluff and the “Annual ‘Top 50′” lists. Those lists won’t tell you what really determines if a company will succeed or just fade away after burning through its funding. During due diligence, you have to ask the hard operational questions that get to the heart of whether a platform can actually scale.

• Payer Coverage Rates and Contracting Models: Forget the pitch deck, what are your actual, verifiable payer coverage rates for virtual cardiology services? What percentage of your contracted lives are actually using the platform? Are your contracts PMPM, value-based, or some hybrid?
• Patient Retention Metrics: Can you show me audited patient retention metrics at 6 and 12 months, broken down by condition and patient type? How are you handling algorithmic drift in your AI models that could hurt long-term engagement?
• Enterprise Implementation Timelines and Resource Requirements: What’s the real average implementation timeline for an enterprise client, from signing to full rollout? What IT, clinical, and admin resources does the health plan or employer have to commit? This gets you to the true cost of ownership for the customer.
• Interoperability and Data Exchange: How good is your bidirectional integration with the big EHR systems and health plan claims data, really? Do you have a real strategy for using real-world evidence (RWE) to prove your value to payers over and over again? ONC Cures Act interoperability guidelines are the minimum standard here.
• Regulatory Posture: What’s the plan after your initial 510(k) or De Novo? How do you stay compliant, especially with AI/ML components that are constantly changing? Do you have a Predetermined Change Control Plan (PCCP) filed with the FDA to manage model updates? These are the questions that expose the “inside story”, the operational grind these platforms endure with health plans. They give investors a real picture of the adoption challenges, separating the companies that can actually scale from the “zombie companies” that can’t close enterprise deals.
  

  Compliance-Ready Companies Spotlight: Hello Heart

  Some companies get this. Look at Hello Heart. In the chronic heart health space, they stand out because they treat compliance as a core part of the business, not an afterthought. Their whole model is a smartphone app and connected devices for hypertension, so they have to be absolutely locked down on data privacy (HIPAA) and security (HITRUST, SOC 2 Type II). Since they sell to employers, they also need to prove their solution actually works, which is why they back it up with peer-reviewed studies. That’s the kind of approach that wins as regulators start paying more attention to the entire digital health industry.

  Methodology Note

  This analysis isn’t just theory. It’s based on interviews we conducted with benefits managers and health plan executives between Q4 2025 and Q2 2026. We also reviewed public health plan formulary lists and corporate investor decks to get a pragmatic, investor-focused view on what’s really happening in chronic heart health virtual care.